Insider · CIK 0001242122

KIRKMAN ROBERT L

Reports to the SEC for 4 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001242122

Forms 4 and 5

Insider transactions

13 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-09-24	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+750K sh	—	—	750,000
2014-12-16	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+300K sh	—	—	300,000
2013-12-12	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+600K sh	—	—	600,000
2012-12-12	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+100K sh	—	—	100,000
2011-12-01	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+100K sh	—	—	100,000
2010-12-01	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+100K sh	—	—	100,000
2010-12-01	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+100K sh	—	—	100,000
2009-12-03	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+200K sh	—	—	200,000
2009-03-11	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+100K sh	—	—	100,000
2009-03-11	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+100K sh	—	—	100,000
2005-02-03	BGMSBio Green Med Solution, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Business Officer and VP	AAward	+40K sh	$2.29	+$91.6K	40,000
2004-12-09	BGMSBio Green Med Solution, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Business Officer and VP	AAward	+40K sh	$2.14	+$85.6K	40,000
2004-04-06	BGMSBio Green Med Solution, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer and VP	AAward	+40K sh	—	—	40,000

Recent filings

Accepted (ET)
Sep 284
Oncothyreon Inc.0001209191-15-072330
SEC(opens sec.gov)
Dec 164
Oncothyreon Inc.0001209191-14-076018
SEC(opens sec.gov)
Dec 164
Oncothyreon Inc.0001209191-13-057151
SEC(opens sec.gov)
Dec 144
KIRKMAN ROBERT L0001179110-12-017642
SEC(opens sec.gov)
Dec 54
KIRKMAN ROBERT L0001179110-11-016092
SEC(opens sec.gov)
Dec 34/A
KIRKMAN ROBERT L0001242122-10-000003
SEC(opens sec.gov)
Dec 34
KIRKMAN ROBERT L0001242122-10-000001
SEC(opens sec.gov)
Dec 44
KIRKMAN ROBERT L0001242122-09-000006
SEC(opens sec.gov)
Mar 184/A
KIRKMAN ROBERT L0001242122-09-000005
SEC(opens sec.gov)
Mar 114/A
KIRKMAN ROBERT L0001242122-09-000004
SEC(opens sec.gov)
Feb 74
KIRKMAN ROBERT L0001130166-05-000023
SEC(opens sec.gov)
Dec 134
KIRKMAN ROBERT L0001130166-04-000033
SEC(opens sec.gov)
Apr 94
KIRKMAN ROBERT L0000907303-04-000087
SEC(opens sec.gov)

Companies

Address

2601 FOURTH AVENUE SUITE 500

SEATTLE, WA, 98121